Inventiva SA (IVAA)

Currency in EUR
4.41
-0.16(-3.40%)
Real-time Data·
IVAA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
4.414.50
52 wk Range
2.566.20
Key Statistics
Prev. Close
4.56
Open
4.5
Day's Range
4.41-4.5
52 wk Range
2.56-6.2
Volume
53.01K
Average Volume (3m)
348.55K
1-Year Change
46.1165%
Book Value / Share
-0.15
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
IVAA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
10.00
Upside
+126.77%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts do not anticipate the company will be profitable this year

Inventiva SA News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and other diseases in France and internationally. The company develops Lanifibranor, a novel pan-peroxisome proliferator-activated receptor agonist that is in the NATiV3 Phase 3 clinical trial to treat adult patients with MASH; and Odiparcil for the treatment of patients with mucopolysaccharidoses. It also develops TGF-ß, a pre-clinical program for the treatment of idiopathic pulmonary fibrosis. The company was incorporated in 2011 and is headquartered in Daix, France.

Compare IVAA to Peers and Sector

Metrics to compare
IVAA
Peers
Sector
Relationship
P/E Ratio
−2.6x−2.4x−0.5x
PEG Ratio
−0.07−0.010.00
Price/Book
−32.8x1.1x2.6x
Price / LTM Sales
138.6x10.3x3.2x
Upside (Analyst Target)
99.6%186.5%45.2%
Fair Value Upside
Unlock1.5%6.4%Unlock

Analyst Ratings

6 Buy
0 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 10.00
(+126.77% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
30/03/2026
EPS / Forecast
-0.93 / -0.30
Revenue / Forecast
2.74M / --
EPS Revisions
Last 90 days

People Also Watch

5.83
ALKAL
+1.04%
0.3840
ALSEN
+0.66%
1.18
ABS
+0.68%
1.1820
IPH
+0.51%
23.98
IPAR
+0.42%

FAQ

What Is the Inventiva (Paris: IVAA) Share Price Today?

The Inventiva stock price today is 4.41 EUR.

What Stock Exchange Does Inventiva (IVAA) Trade On?

Inventiva is listed and trades on the Paris Stock Exchange.

What Is the Ticker (Stock Symbol) for Inventiva?

The stock symbol (also called a 'ticker') for Inventiva is "IVAA."

What Is the Current Inventiva Market Capitalisation?

As of today, Inventiva (Paris: IVAA) market cap is 920.14M EUR.

What Is Inventiva's (IVAA) Earnings Per Share (TTM)?

The Inventiva EPS is currently -1.90 (Trailing Twelve Months).

When Is the Next Inventiva Earnings Date?

Inventiva's next earnings report will be released on 26/05/2026.

Is IVAA a Buy or Sell From a Technical Analyst Perspective?

Based on today's Inventiva moving averages and other technical indicators, the daily buy/sell signal for IVAA stock is Strong Sell.

How Many Times Has Inventiva Stock Split?

Inventiva has split 0 times. (See the IVAA stock split history page for full effective split date and price information.)

How Many Employees Does Inventiva Have?

Inventiva has 73 employees, based on their latest Companies House report.

What is the current trading status of Inventiva (Paris: IVAA)?

As of 23/04/2026, Inventiva (IVAA) is trading at a share price of 4.41 EUR, with a previous close of 4.56 EUR. The stock has fluctuated within a day range of 4.41 EUR to 4.50 EUR, while its 52-week range spans from 2.56 EUR to 6.20 EUR.

What Is Inventiva (IVAA) Price Target According to Analysts?

The average 12-month price target for Inventiva is 10.00 EUR, with a high estimate of 15.502 EUR and a low estimate of 7 EUR. 6 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +126.77% Upside potential.

Industry Spotlight

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.